Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.694 USD | +1.40% | -1.56% | -26.75% |
Financials (USD)
Sales 2024 * | 2M | Sales 2025 * | 3.33M | Capitalization | 50.52M |
---|---|---|---|---|---|
Net income 2024 * | -94M | Net income 2025 * | -106M | EV / Sales 2024 * | 25.3 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 15.2 x |
P/E ratio 2024 * |
-0.56
x | P/E ratio 2025 * |
-0.57
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.16% |
Latest transcript on Kezar Life Sciences, Inc.
1 day | +1.40% | ||
1 week | -1.56% | ||
1 month | -17.23% | ||
3 months | -32.62% | ||
6 months | -17.19% | ||
Current year | -26.75% |
Managers | Title | Age | Since |
---|---|---|---|
Christopher Kirk
FOU | Founder | 52 | 15-02-18 |
John Fowler
FOU | Founder | 52 | 15-02-18 |
Marc Belsky
DFI | Director of Finance/CFO | 68 | 18-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 15-12-31 |
Graham Cooper
CHM | Chairman | 54 | 17-09-30 |
Michael Kauffman
BRD | Director/Board Member | 60 | 16-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.05% | 0 M€ | 0.00% | - | |
0.04% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.694 | +1.40% | 475,630 |
24-05-30 | 0.6844 | -0.62% | 845,539 |
24-05-29 | 0.6887 | -3.27% | 679,903 |
24-05-28 | 0.712 | +0.99% | 611,638 |
24-05-24 | 0.705 | -3.24% | 497,104 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.75% | 50.52M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- KZR Stock